Stocks
AnaptysBio (ANAB) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -1 199% | -25.8% | -88.2% | -1 023% | -834.4% | -219.7% | ||
| Changes by years, y/y, % | +5pp | +1 173pp | -62pp | -935pp | +189pp | -7.1% | |||
AnaptysBio. EBITDA margin, %
AnaptysBio. EBITDA margin, changes, pp
AnaptysBio (ANAB) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -973.0% | -407.0% | -515.6% | -320.0% | -56.1% | -219.7% | |
| Changes by years, y/y, % | +1 098pp | -82pp | +2 390pp | +689pp | +917pp | |||
| Changes by quarters, q/q, % | +36pp | +566pp | -109pp | +196pp | +264pp | |||
